Suresh Ramalingam on Toxicities Associated With Immunotherapy in Different Disease Types

Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

A new algorithm has found that combining immune checkpoint inhibitors bolsters immune response among some patients with advanced melanoma.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

Cancer-related fatigue is felt physically, mentally and emotionally, which can significantly affect one’s quality of life.

Although early palliative care may not increase quality of life short term, it can help with coping skills in patients with advanced cancers.